Google Search

Search

Already a Member ?

Healthcare and Medical Businesses

Health is a primary human right and has been accorded due importance by the Constitution through Article 21.Though Article 21 stresses upon state governments to safeguard the health and nutritional well being of the people, the central government also plays an active role in the sector. Recognizing the critical role played by the Health Industry, the industry has been conferred with the infrastructure status under section 10(23G) of the Income Act.

The healthcare sector is one of the most challenging and fastest growing sectors in India. Revenues from the healthcare sector account for 5.2 per cent of the GDP, making it the third largest growth segment in India.

The Indian Health sector consists of

-Medical care providers like physicians, specialist clinics, nursing homes, hospitals.

-Diagnostic service centers and pathology laboratories.

-Medical equipment manufacturers.

-Contract research organizations (CRO's), pharmaceutical manufacturers

-Third party support service providers (catering, laundry)

The healthcare industry in the country, which comprises hospital and allied sectors, is projected to grow 23 per cent per annum. According to McKinsey & Co. a leading industrial and management consulting organization, the Indian healthcare sector, including pharmaceutical, diagnostics and hospital services, is expected to more than double its revenues to Rs 2000 billion by 2010. Expenditure on healthcare services, including diagnostics, hospital occupancy and outpatient consulting, the largest component of this spend is expected to grow more than 125% to Rs 1560 billion by 2012 from Rs 690 billion now.

The sector has registered a growth of 9.3 per cent between 2000-2009, comparable to the sectoral growth rate of other emerging economies such as China, Brazil and Mexico. According to the report, the growth in the sector would be driven by healthcare facilities, private and public sector, medical diagnostic and pathology labs and the medical insurance sector.

Healthcare facilities, inclusive of public and private hospitals, the core sector, around which the healthcare sector is centered, would continue to contribute over 70 per cent of the total sector and touch a figure of US$ 54.7 billion by 2012. Adds a FICCI-Ernst and Young report, India needs an investment of US$ 14.4 billion in the healthcare sector by 2025, to increase its bed density to at least two per thousand populations.

Technological advances achieved by medicare globally in the recent years have been phenomenal. The Indian scenario has not remained immune to these changes. While IT (information technology) has come to the aid of the breakthroughs, the progress recorded in the medicare area is as impressive as it is in the IT sector itself. The changes are in concepts, forms and content, as well as applications. These are both, quantitative and qualitative. The transformation is pervasive and has penetrated almost all specialities, from diagnostics to physiotherapy, from cardiology to oncology, from non-invasive surgery to transplants. In India, the emergence of private medicare services, especially through commercialization and corporatization, has contributed to the transformation. The rapid commercialization of the medical practices with the establishment of multi-million rupee hospitals, nursing homes and diagnostic centres, specialized and general, the demand has registered a very high growth rate in the recent years.

Medical sector in India got tax exemptions in the manufacturing of its devices from Union Budget 2010-11 along with the introduction of excellent initiatives towards the development of the sector. The FM has proposed to extend the tax exemption on medical apparatus and devices and concessional tariff available to certified government hospitals. Moreover, the producers of orthopaedic implants have been relieved from import tax.

The incentives proposed by the FM are expected to trigger the expansion of already fast developing medical apparatus and machinery sector in India. By 2010 the medical apparatus and machinery industry is estimated to reach USD 1.8 billion and is projected to expand at a rate of 23% on annual basis as per the NIPER report.

This time the focus of the budget was on rural healthcare, with the fund allocations rising to a whopping 22,300 crores (Rs 223 billion/$4.82 billion) from 19,534 crores during the previous fiscal year. This escalation is in keeping with the evolving needs of the growing healthcare industry of the country. Relaxation of FDI norms may see more international players coming in to India in the healthcare sector. Added to it, rationalization of duties on medical equipment can make imports cheaper and can significantly lower healthcare costs in the country in the coming years.

The government, along with participation from the private sector, is planning to invest US$ 1 billion to US$ 2 billion in an effort to make India one of the top five global pharmaceutical innovation hubs by 2020. The sector has been attracting huge investments from domestic players as well as financial investors and private equity (PE) firms. The Indian market is expanding in all directions as a result of better affordability, greater health consciousness and expanding medical service institutions.

We can provide you detailed project reports on the following topics. Please select the projects of your interests.

Each detailed project reports cover all the aspects of business, from analysing the market, confirming availability of various necessities such as plant & machinery, raw materials to forecasting the financial requirements. The scope of the report includes assessing market potential, negotiating with collaborators, investment decision making, corporate diversification planning etc. in a very planned manner by formulating detailed manufacturing techniques and forecasting financial aspects by estimating the cost of raw material, formulating the cash flow statement, projecting the balance sheet etc.

We also offer self-contained Pre-Investment and Pre-Feasibility Studies, Market Surveys and Studies, Preparation of Techno-Economic Feasibility Reports, Identification and Selection of Plant and Machinery, Manufacturing Process and or Equipment required, General Guidance, Technical and Commercial Counseling for setting up new industrial projects on the following topics.

Many of the engineers, project consultant & industrial consultancy firms in India and worldwide use our project reports as one of the input in doing their analysis.

We can modify the project capacity and project cost as per your requirement.
We can also prepare project report on any subject as per your requirement.

Page 9 of 13 | Total 128 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13   Next »

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Select all | Clear all Sort by

FRUIT PROCESSING (Mango, Lychee, Pineapple, Orange & Pomelo for Concentrates, Juice in Cans) - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials

Juice is the liquid that is naturally contained in fruit or vegetable tissue. Juice is prepared by mechanically squeezing or macerating fresh fruits or vegetables flesh without the application of heat or solvents. For example, orange juice is the liquid extract of the fruit of the orange tree. Juice may be prepared in the home from fresh fruits and vegetables using a variety of hand or electric juicers. Many commercial juices are filtered to remove fiber or pulp, but high-pulp fresh orange juice is a popular beverage. Juice may be marketed in concentrate form, sometimes frozen, requiring the user to add water to reconstitute the liquid back to its "original state". However, concentrates generally have a noticeably different taste from that of their "fresh-squeezed" counterparts. Other juices are reconstituted before packaging for retail sale. Common methods for preservation and processing of fruit juices include canning, pasteurization, freezing, evaporation and spray drying. Fruit juices consist of 100% pure fruit juice made from the flesh of fresh fruit or concentrates and contain no preservatives or any other added ingredients. Some minor exceptions exist in order to ensure that the final product is of an acceptable taste. These exceptions are very specific and are controlled by government legislation in the form of the Fruit Juices & Nectars Regulations. The branded fruit juices market inclusive of nectars is placed at about Rs 10 billion. The pure fruit juices are the preferred drink among the fruit drinks. This segment is growing at around 10% annually. The market for fruit juices is expected to grow to Rs. 7.50 billion by end 2009-10 from nearly Rs. 4.75 billion presently. Consumption per capita of juices in India is very low. It is estimated at a fraction of a liter - 20 ml. China has attained a consumption level of 1500 ml. The consumption in India is basically an urban phenomenon. Nonetheless, it is gaining slow but steady penetration into the rural areas. The market size of the food processing industry is likely to increase from Rs 4600 billion in 2003-04 to Rs 8200 billion in 2009-10, and to Rs 13,500 billion in 2014-15.In the coming years India’s share in the global processed food industry will get a raise from one per cent to three per cent. Indian food processing activity is still largely based on primary processing, which accounts for 80 per cent of the value addition. In the area of packaging, Tetra-Pak India, a part of the $ 10 billion Tetra Laval group, has become the major source of brick cartons amenable to aseptic packaging and imparting long product shelf-life to the foods. Tins, nonetheless still continue to be in the market in family size packing. There is an ample space and good market potential for new entrepreneurs in this field.
Plant capacity: 1475 Kls/Annum Fruit Juice, 25 MT/Annum Fruit Juice ConcentratePlant & machinery: 210 Lakhs
Working capital: -T.C.I: 580 Lakhs
Return: 44.00%Break even: 39.00%
Add to Inquiry Add to Inquiry Basket

BLOOD BAGS - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Blood bag is a disposable bio-medical device used for collection, storage, transportation and transfusion of human blood and blood components. The system consist of a single or multiple bag connected with tubing’s, needle, needle cover, clamp etc. The Blood Bags are made of plastic-material, which are compatible with blood. Plasticized-PVC blood bags have been used since the 1950s for the collection of whole blood, the processing of this into plasma, platelets etc., and storage. The phthalate plasticizers, when fed in large quantities to rats, can cause cancer. This does not prove that the storage of whole blood in plasticized PVC bags is a health risk. However, there has been a search for alternative polymers for blood bags. Blood Bags can successfully replace the use of glass bottles for collection storage, transportation and transfusion of blood and blood components since bottles require exhaustive cleaning, rinsing and autoclaving procedures and there are chances of breakage at any stage. Further, use of disposable bags eliminates the possibility of any contamination. In recent times, Blood Bags have become a conspicuous item and a dire need of hospitals and nursing homes to meet blood - infusion emergencies. Blood Bags are most ostensibly serving the medical field in crucial hour. As the number of hospital, nursing home & etc are increasing, the demand for the blood bags, too, is increasing tremendously. Technologies advances achieved by medicare in the recent years have been historic. The Indian scenario has not remained immune to these changes. While IT (information technology) has come to the aid of the breakthroughs, the progress recorded in the medicare area is as impressive as it is in the IT sector itself. The changes are in both, form and content, as well as quantitative and qualitative. These have pervaded almost all specialities, from diagnostics to physiotherapy, from cardiology to oncology, from non-invasive surgery to transplants. In India, the emergence of private medicare services, especially through commercialization and corporatization, has contributed to the transformation. Thanks to rapid commercialization of the medical practices with the establishment of multimillion hospitals, nursing homes & diagnostic centres (specialized and general) the demand has registered a very high growth rate in the recent years. There is a good scope and market potential for new entrepreneurs to venture into this field.
Plant capacity: 30000 Nos./Day Each Bag of Capacity – 450 ML.Plant & machinery: 281 Lakhs
Working capital: -T.C.I: 2186 Lakhs
Return: 45.00%Break even: 36.00%
Add to Inquiry Add to Inquiry Basket

PACKAGED DRINKING WATER, SODA WATER AND PET BOTTLES - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Cost of Project

Bottled Water means water intended for human consumption and which is sealed in bottles and other containers with no added ingredients except that it may occasionally contain safe anti-microbial agent. Now-a-days safe and pure drinking water is major necessity for human being. Bottled water industry, colloquially called, the mineral water industry, is a symbol of new life style emerging in India. While a large segment of the population is struggling to get access to potable water supply, a new generation - especially in the urban areas is getting accustomed to bottled water paying handsome prices. Soda water is water which is carbonated and thus made bubbling by the addition of carbon dioxide gas under pressure. Soda water is sometimes used to dilute strong alcoholic drinks, e.g. cocktails such as a whisky and soda, or Campari and soda. It can also be drunk on its own. Soda water gets its name from the sodium salts it contains, said 'salty' compounds adding a distinct and pleasurable quality to many beverages of the alcoholic and non-alcoholic type. PET is the most extensively recycled plastic of the present time. Bottled water is available in differently sized packaging from 200 ml (popular on flights) to 500 ml (a huge hit among the youth) to 1 liter and 2 liter. Despite the large number of small producers, this industry is dominated by the big players – Parle, Bisleri, Coca-cola, Pepsico, Parle Agro, Mohan Meakins, SKN Breweries bottled water in the country when it introduced Bisleri in India 25 years ago. Apart from domestic and commercial use of packaged water, the Indian Railways is a huge potential market. According to officials at Cheerio, the railway ordered 10,000 cases (of 12 bottles each) a day. In coming years the demand of packaged drinking water will be increased very rapidly, so there is a huge scope for new entrepreneurs to venture into this project. The bottled water market is growing at a rapid rate of around 20% a year (down from 50 to 60%). At this growth rate, the Rs 7000 million per year market is estimated to overtake the soft drinks market soon. Multinationals, Coca-Cola, Pepsi, Nestle and others are trying to grab a significant share of the market. There are more than 180 brands in the unorganized sector. The small players account for nearly 19% of the total market. The government decided towards end of the year 2000 to bring about stringent guidelines for packaged water. All companies were made to sell their products only under the BIS (Bureau of Industrial Standards) certification mark. The BIS certification was made mandatory for the segment from April 1, 2001. The bottled water is to be classified as "food" and has been brought under the Prevention of Food Adulteration Act. They would have to adhere to rules pertaining to colour, odour, taste, turbidity, total dissolved solids and aerobic microbial count. There is a good scope and good market potential for new entrepreneurs to venture into this field. Cost Estimation:
Plant capacity: Drinking Water – 17280000 Nos. Bottles (1 Ltr.)/Annum,Soda Water – 1008000 Nos. Bottles (600 Ml)/Annum,Drinking Water Jar – 720000 Nos. Jar (20 Ltr.)/AnnumPlant & machinery: 403 Lakhs
Working capital: -T.C.I: Cost of Project : 695 Lakhs
Return: 44.00%Break even: 60.00%
Add to Inquiry Add to Inquiry Basket

TAURINE - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Taurine, or 2-aminoethanesulfonic acid, is an organic acid. It is a major constituent of bile and can be found in the lower intestine and, in small amounts, in the tissues of many animals, including humans. Taurine is a derivative of the sulfur-containing (sulfhydryl) amino acid cysteine. Taurine is one of the few known naturally occurring sulfonic acids. Taurine is possibly best known as a health supplement, and is used in a variety of products. Bodybuilders take supplements of taurine coupled with creatine which may help in reducing muscle fatigue and soreness. Energy drinks, which are becoming hugely popular, especially among the teen and young adult set, often list taurine as one of its main supplemental ingredients. Applications: The main use of taurine is in infant formula to make it more like human milk (cow's milk is deficient in taurine). Taurine is also used in a wide variety of different functional drinks, ranging from "smart drinks" to "energy tonics" and is often used in conjunction with caffeine. Taurine is used in milk, dairy products, beverages, supplements, complex monosodium glutamate and certain specific foods. In the recent research on the effect of taurine on human intelligence and health, it has been discovered that taurine plays an active role in promoting the development of brain, maintaining the physiological functions of retina, regulating the conduction of nerve, enhancing the absorption and the acid- base metabolism of gall and promoting the functions of heart, liver and internal secretion. Emerging application: The new applications include that taurine can be used to treat “hangover” symptoms caused by excessive drinking and help the treatment of anxiety disorders and obesity. In the future, the demand from weight control food and alcoholism preventing health care products will drive the continuing growth of the international taurine consumption. A deficiency may impair vision and problems with fat metabolism may appear. Synthetic taurine is obtained from isethionic acid (2-hydroxyethanesulfonic acid), which in turn is obtained from the reaction of ethylene oxide with aqueous sodium bisulfite. Another approach is the reaction of aziridine with sulfurous acid. This leads directly to taurine. The global demand for taurine is in the region of 100 000 tonnes per annum and It is expected that the annual growth rate of the international taurine market will reach 15% in the few years. The import of taurine to India is around 11-12 MT per annum. There is an ample space and market for this product. Major taurine producers:Hubei Qianjiang Yongan Pharmaceutical Co., Ltd, China, Hubei Fu Chi chemical Pharmaceutical Co., Ltd,China , Changshu Renoke Food-additive Science Co., Ltd, China and others.
Plant capacity: -Plant & machinery: -
Working capital: -T.C.I: -
Return: 1.00%Break even: N/A
Add to Inquiry Add to Inquiry Basket

STEVIA extract: Stevioside - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

PRODUCT PROFILE Stevioside is a high intensity sweetener 250300 times that of sucrose, intended to be used in a wide range of low or reduced calorie food products and beverages. Stevia is the only natural sweetener available in the market. However, the sweet taste is not due to carbohydrate based molecules, but to several non caloric molecules called glycosides. Individuals who cannot tolerate sugar or other sweeteners can use stevia. Stevia is an artificial sweetener that has been widely used in most foods as well as beverages in the US as calorie free sweetener. It reduces the calories from your food which makes it a suitable replacement of sugar for calorie conscious as well diabetic people. It is also being found by people that the regular use of stevia helps in reactivating the insulin secreting cells in pencreas. The raw stevia leaves are around 35 to 40 times sweeter than sugar, stevia extract are sweet upto 300 times of ordinary sugar. The stevia is safest low calorie sweetener without any side effect. Stevia and steavia powder extract are marketed in many countries across the globes. Product characteristics Trade names - Stevioside Appearance - White crystalline powder Description - Natural sweetener Shelf life - Good Applications • Majorly used as a pre packaged replacement for sugar and artificial sweeteners, in various food products. • Stevia is also useful in lowering blood sugar • Reduces the tooth cavity hence it can be used in tooth pastes in place of sugar to avoid tooth decay • Stevia leaf powder can be used as a face pack with rose water as it possesses great anti wrinkle qualities in it • It can prevent people from hypertension, diabetes mellitus, obesity, heart disease • Used in Japanese style pickles, dried seafood, fish meat products, vegetables and seafood boiled down with soy sauce, confectioneries and a host of other products. Global demand India’s production 600 metric ton per annum Stevia is poised for major growth in the Indian cash crop market as domestic and export demand pick up. Stevia production is likely to leap by as much as 300% over the next three years, according to Dr N Barathi, director of Grow more Biotech and Member of the 10th Planning Commission (Sub Group on Hi Tech Horticulture). Worldwide, 80,000 acres are covered under Stevia cultivation, of which China has a major chunk of 75%. In the last three years, the Indian farmers have also started taking up Stevia cultivation following the large demand for diabetic market here. Indian climate condition is most viable for the Stevia cultivation, which requires temperature of 15 to 25 degree Celsius. The country’s total annual production is nearly 600 tonnes. Since the applications and demand of Stevia is immense therefore the potential of the product is excellent. It is one of the imperative fields to endeavour. Cost Estimation: Capacity: 135000 packs 100gm/Annum 67500 packs 200gm/Annum, 33750 packs 400gm/ Annum 13500 packs 1 kg/Annum
Plant capacity: -Plant & machinery: 84 Lakhs
Working capital: -T.C.I: Cost of project: 274 Lakhs
Return: 44.00%Break even: 56.00%
Add to Inquiry Add to Inquiry Basket

Hospital - Detailed Project Report, Profile, Business Plan, Trends, Market Research, Survey, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics, Working Capital Requirement, Plant Layout, Cost of Project,Projected Balance Sheet

A private hospital is a place where one may get treatment from ordinary fever to a major surgery operation. As a matter of fact, no limitation has been made for the facilities available in a hospital. However, generally all private hospitals are provided with latest facilities and ultra modern machines. In a hospital, surgeons, physicians, E.N.T., specialists, children specialist, Eye-surgeon, psychologists and sex-specialist are essential. Presently, every city or town in India has no. of private hospitals furnished with latest medical facilities available and with more qualified surgeons, physicians and specialist doctors. Even sometimes, they are furnished with more modern machines than those available in the nearby Government Hospital. These hospitals can be seen well crowded as they provide very good service at a smile. As they are run by privates very good medical care is provided by them. Development in Healthcare Industry: The Indian healthcare industry is undergoing phenomenal expansion. Private hospitals and continued investment in the public health programmes are driving the boom. Together, this health infrastructure serves a population of over 1 billion, growing at about 2 per cent annually. India’s over 300 million strong middle class, is driving unprecedented demand for quality healthcare. Market Scenario: Based on the health indicators for India released by the WHO, CRISIL Research estimates the Indian healthcare delivery industry to reach Rs 2.3 trillion in 2010-11. As healthcare coverage across the country increases, the industry is expected to register a CAGR of 12 per cent to reach Rs 4.2 trillion in 2015-16. As private investments have been skewed towards in-patient department (IPD) treatments, its share in the overall market is expected to increase from 64 per cent in 2010 to 11 to 66 per cent by 2015 to 16. The growth in demand for healthcare delivery services will be mainly driven by a combination of various factors including changing demographics, increasing income levels, greater health awareness and increasing health insurance coverage. Investments of over Rs 5.6 trillion required to attain healthcare delivery benchmarks. India lags behind several global benchmarks for healthcare delivery. In terms of both healthcare infrastructure and manpower, India ranks below even developing countries like China, Thailand, Sri Lanka and Vietnam in terms of both beds to population and physicians to population ratios. In order to meet the global median of 24 beds per 10,000 population, as per WHO statistics, investments of Rs 5.6 trillion would be required over the next 5 years.
Plant capacity: 100 BEDDED HOSPITAL Plant & machinery: 3889 Lakhs
Working capital: -T.C.I: 5275 Lakhs
Return: 19.04%Break even: 57.99%
Add to Inquiry Add to Inquiry Basket

Disposable Plastic Syringes - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue

A syringe is a simple piston pump consisting of a plunger that fits tightly in a tube. The plunger can be pulled and pushed along inside a cylindrical tube allowing the syringe to take in and expel a liquid or gas through an orifice at the open end of the tube. The open end of the syringe may be fitted with a hypodermic needle, a nozzle, or tubing to help direct the flow into and out of the barrel. The disposable plastic syringe has become an important part of the medical scene since its introduction in the late 1950's. Today more and more attention is being focused on the composition and configuration of this everyday item. It is an instrument which is used for injecting any liquid into the body of human beings or of animals. These syringes are used for injecting the medicine into the body or into the nerve of the body which are not possible to take in through mouth or takes much time in mixing with blood. Disposable Syringes made of plastic Material have been successfully used in medical and pharmaceutical practice for many years. The constantly increasing use of this type Syringe indicates its importance, which is based mainly on the advantages it offers regarding cost and hygienic applications. Uses & Applications Disposable syringes commonly are used in modern medicine for the injection of drugs and vaccines or for the extraction of blood. The often are used instead of reusable syringes in an effort to avoid spreading a disease. Among the common uses of disposable syringes are the injecting of insulin by a diabetic person and the administering of a local anesthesia by a dentist .A medical syringe that is used to give shots to more than one person without being properly sterilized is a potential source of disease. This can be an especially pressing concern in poor or undeveloped areas, where an injection often cannot be given under ideal medical conditions. Market Survey The Health Ministry of the Government of India was planning to have a separate wing to license medical devices under the proposed National Drug Authority. The Indian domestic Medicare devices industry is expected to grow from Rs 60 bn to Rs 76.5 bn in four years. The overall market is estimated at Rs 150 bn. A major part of the demand is met through imports. Devices, such as catheters and stents represent nearly two fifth of the entire range of diagnostic devices and most critical as per international classification. The Government has decided to create separate quality guidelines for medical devices. Presently medical devices are treated like drugs and regulated by state drug regulators under the drug law Drugs and Cosmetics Act. Guidelines would make it mandatory for producers to get their products certified by notified bodies like ISO and BIS. Technological advances achieved by Medicare globally in the recent years have been phenomenal. The Indian scenario has not remained immune to these changes. While IT (information technology) has come to the aid of the breakthroughs, the progress recorded in the Medicare area is as impressive as it is in the IT sector itself. The changes are in concepts, forms and content, as well as applications. These are both, quantitative and qualitative. The transformation is pervasive and has penetrated almost all specialties, from diagnostics to physiotherapy, from cardiology to oncology, from non invasive surgery to transplants. Financial Analysis & Comparison of Major Companies Albert David Ltd. Disposable Medi Aids Ltd. H L L Lifecare Ltd. Hindustan Syringes & Medical Devices Ltd. Iscon Surgicals Ltd. La Medical Devices Ltd. Lifeline Injects Ltd. Lifelong Meditech Ltd. Nirma Ltd. Raaj Medisafe India Ltd. Sangam Health Care Products Ltd. Surgiplast Ltd.
Plant capacity: 33600 NOS./DayPlant & machinery: 112 Lakhs
Working capital: -T.C.I: Cost of Project : 287 Lakhs
Return: 30.00%Break even: 44.00%
Add to Inquiry Add to Inquiry Basket

Tissue Paper - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Paper is one of the necessities of civilization and it is almost impossible to imagine the continuance of a world without the printed books and newspapers. People require paper to meet the basic needs of modern life because it has many diverse uses. Modern paper is made from cellulose derived from a limited numbers of plants, the fibres being mixed with sufficient water to render possible formation of a continuous sheet of paper of uniform thickness. Paper spread from China through the Middle East to medieval Europe in the 13th century, where the first water powered paper mills were built. In the 19th century, industrial manufacture greatly lowered its cost, enabling mass exchange of information and contributing to significant cultural shifts. In 1844, Canadian inventor Charles Fenerty and German F.G. Keller independently developed processes for pulping wood fibers. Vegetable fibres of all kinds may be converted into paper among the various types of paper serving different end uses. Tissue paper is a lightweight paper or, light crêpe paper. Tissue can be made both from virgin and recycled paper pulp. Tissue and Airmail papers are required for very specific purposes. Wipes, kitchen towels, handkerchiefs, facial tissues, household towels, napkins, products for industrial use, etc. Some tissue paper products, in particular kitchen towels and napkins, are sometimes put in contact with food by end users. These products exhibit the typical characteristics of tissue paper, such as softness, high absorption capacity and limited structural strength. Uses & Application Tissue paper is used in a wide variety of arts and crafts. It is used in college, mosaics, stamping, gift wrapping, papier mâché, ornaments, garlands, paper flowers, paper sculpture. Some tissue paper is guaranteed not to bleed, and some is designed to bleed so that water can be applied and the color used to create artistic effects. Tissue paper is often used for direct inside part wrapping as in the jewellery, liquor, fruit and florist trades, various other tissue papers are used for specific purposes. Napkins are manufactured from Tissues. Paper Napkin age becoming popular with catering Industry due to its manifold uses. These are absorbent, hygienic light and can be had with attractive printing. Facial Tissue paper though recently introduced in Indian market is fast becoming popular with the public Facial tissue is fast becoming popular with the public due to its lightness, absorbent, hygienic and handy in nature. Toilet tissues are becoming immensely used for sanction by almost all the big hotels, restaurants, cinema & houses etc. Market Survey The world consumption of paper and paperboard is estimated at over 300 mn tonne a year. It is constituted broadly of 30% of cultural papers (writing and printing), 14% of newsprint, and the balance of kraft and packaging paper including paperboards. The Indian production is about 2 to 3% of the global total. The overall value of the market is estimated at Rs 250 bn. In volume terms, the segment is presently estimated at over 6.9 mn tonne. It is expected to expand to 9.2 mn tonne in 2010 to 11.However, despite all the announced capacity expansions, India would still have a supply gap in 2010. The Indian market is today growing at three times the rate of the global average. India's paper industry plans to invest USD 2.5 bn in the next two three years to add 2 mn of paper and paper products production capacity. It will also help in improving cost competitiveness. The domestic demand for paper is growing at around 8% for the last couple of years in line with GDP growth. However, the per capita consumption in the country is only 8 kg a year. As a result of this low base, the long term growth prospects are bright. The government's thrust on education and special schemes are expected to help the industry in future. Financials & Comparison of Major Players/Companies Orient Paper & Inds. Ltd. Pamwi Tissues Ltd. Premier Tissues India Ltd. Tainwala Healthcare Products Pvt. Ltd.
Plant capacity: 6 MT/DayPlant & machinery: 53 Lakhs
Working capital: -T.C.I: Cost of Project : 347 Lakhs
Return: 29.00%Break even: 60.00%
Add to Inquiry Add to Inquiry Basket

Soya Protein - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities, Cost and Revenue, Plant Economics

Soy protein is a protein that is isolated from soybean. It is made from soybean meal that has been dehulled and defatted. Soy protein is generally regarded as the storage protein held in discrete particles called protein bodies, which are estimated to contain at least 60 to 70% of the total soybean protein. The health benefits of soy protein powders are coming from the soy protein and the associated isoflavones. The soy protein has a high biological value and contains all essential amino acids. Soy isoflavones have been recognized for many health benefits, including lowering the risk of heart disease, breast cancer, prostate cancer and osteoporosis. Soy isoflavones act as anti cancer agents because they are antioxidant, inhibit the growth of blood vessels required to feed tumours and inhibit the protein production in cancer cells. Soy isoflavones are also beneficial for menopausal women because they may ease menopausal symptoms and help to maintain strong bones. Uses and Applications Soya Protein is used in Meat Products, Sea food Products, cereal products, dairy type products, infant formulas. Partially hydrolysed soy proteins possess good foam stabilization properties and can be used as whipping agents in combination with egg albumen or whole eggs in confectionery products and deserts. Isolated soybean protein has been shown to be an effective spray drying aid in fruit purees. In this application, it can replace maltodextrins, with the advantage of contributing protein to the final product. Market Survey This market is driven by the nutritive, functionally properties, and the health benefits achieved. The largest market for the soy protein ingredients is in the North American region, whereas Asia Pacific market is predictable to register best growth opportunities. Moreover, China and India will be the fastest growing country in global soy protein ingredients market as its strong economic growth continues. Latin America is the second fastest growing region and Brazil is the major market for soy protein ingredients. North America and European regions are expected to show moderate growth rate. Soy protein is becoming more prevalent in the world marketplace. Major crop and oilseed processors are recognizing this demand and developing products accordingly. India’s current and projected population levels and the state of the economy show the country is poised for a transition of diets that are higher in protein content. Few Indian Major Players are as under: Acropetal Technologies Ltd. Amar Remedies Ltd. Bliss G V S Pharma Ltd. Genomics Biotech Ltd. Indiaco Health Care Pvt. Ltd. Pan Herbo Ltd. Paramount Surgimed Ltd. Premier Proteins Ltd. Proline Technologies Ltd. Protchem Industries (India) Ltd.
Plant capacity: 10 MT/DayPlant & machinery: Rs.134 Lakhs
Working capital: -T.C.I: Cost of Project : Rs.522 Lakhs
Return: 34.00%Break even: 54.00%
Add to Inquiry Add to Inquiry Basket

L-LYSINE FROM MICROBIAL FERMENTATION - Manufacturing Plant, Detailed Project Report, Profile, Business Plan, Industry Trends, Market Research, Survey, Manufacturing Process, Machinery, Raw Materials, Feasibility Study, Investment Opportunities

L-Lysine is an ?-amino acid with the chemical formula HO2CCH(NH2)(CH2)4NH2. It is an essential amino acid for humans. Lysine's codons are AAA and AAG. Lysine is a base, as are arginine and histidine. The ?-amino group often participates in hydrogen bonding and as a general base in catalysis. (The ?-amino group (NH3+) is attached to the fifth carbon beginning from the ?-carbon, which is attached to the carboxyl (C=OOH) group. Common posttranslational modifications include methylation of the ?-amino group, giving methyl-, dimethyl-, and trimethyllysine. The latter occurs in calmodulin. Other posttranslational modifications at lysine residues include acetylation and ubiquitination. Collagen contains hydroxylysine, which is derived from lysine by lysyl hydroxylase. O-Glycosylation of hydroxylysine residues in the endoplasmic reticulum or Golgi apparatus is used to mark certain proteins for secretion from the cell. Lysine is one of the essential amino acids not synthesized biologically in the body. Children and growing animals have a high requirement of lysine, since it is needed for bone formation. Lysine is generally recognized as the most deficient amino acid in the food supply of both man and domestic meat producing animals. Since animal feed, such as grain and defatted oil seeds contain only small quantities of lysine, poultry, cattle and other live stocks are unable to synthesize this amino acid. So it must be added to these feed stuff to provide adequate diet. The excretion of small amount of alanine, glutamic acid, aspartic acid and histidine in a culture of E. coli. addition of ammonium salt in excess of that required for growth resulted in increased amino acid production. The principles of the fermentative method quickly gained acceptance, and systematic work soon began on the production of other amino acids. This marked the birth of the amino acid fermentation industry.The possible utilization of wild strain revealed that many microorganisms, such as bacteria, yeast, filamentous fungi and action mycetes, accumulated amino acids in culture containing a supplementary source of nitrogen. The biosynthetic pathways of most amino acids are now well moved to metabolic control and its break down, including the genus and species specificity of the phenomenon. Protein production by microorganisms rich in essential amino acids are source both as a food supplement and as a source of amino acid. Fifteen amino acids were found in cell hydrolyzate, of which arginine and L-lysine is the most abundant. Most natural strains cannot produce industrially significant amounts of L-lysine in the culture broth due to various metabolic regulation mechanisms. Alteration of these mechanism can lead to L-lysine accumulation. USES & APPLICATION Lysine production for animal feed is a major global industry, reached in 2009 almost 700,000 tonnes for a market value of over €1.22 billion. Lysine is an important additive to animal feed because it is a limiting amino acid when optimizing the growth of certain animals such as pigs and chickens for the production of meat. Lysine supplementation allows for the use of lower-cost plant protein (maize, for instance, rather than soy) while maintaining high growth rates, and limiting the pollution from nitrogen excretion. In turn, however, phosphate pollution is a major environmental cost when corn is used as feed for poultry and swine. Lysine is industrially produced by microbial fermentation, from a base mainly of sugar. Genetic engineering research is actively pursuing bacterial strains to improve the efficiency of production and allow lysine to be made from other substrates. The requirements of amino acids in animals are well defined in various sets of recommendations such as those of NRC (National Research Council), USA, etc. Requirements vary depending on the species and age of animals. Amino acids should be supplied either in the form of protein or crystalline amino acids in feed to meet requirements. By comparing requirements and the actual amino acids present in feed, the order of ‘limiting amino acids’ can be estimated. The orders of limiting amino acids in pig and broiler feeds, composed of corn (or wheat) and soybean meal. Crystalline amino acids should be added to feed in the order of limiting amino acids when the protein content of the feed is reduced, which is the reason why DL-Methionine and L-Lysine HCl were initially introduced to feed. Now, with a more economic supply of L-Threonine and L-Tryptophan available, use of amino acids has entered a new era, in which the use of second and third limiting amino acids is taking off. For example, in the past two to three years, the annual growth rate of L-Threonine usage has been above 20 percent. Since the protein level required by livestock is reduced further with the introduction of second and third limiting amino acids, use of the first limiting amino acid will also be expanded. MARKET SURVEY It can be said that the use of L-Lysine in animal feed in India is largely in the introductory stage at present. The demand is bound to go up, in view of the compulsive need to optimise the quality of the animal feed by the producers to stay ahead in the competitive market. The Indian demand for L-Lysine is estimated to be around 1000 tonnes per annum. Estimated growth rate in demand: 9 to 10% per annum. The global demand for L-Lysine Hydrochloride is around 5,00,000 tonnes per annum with the projected growth rate in demand of around 8.0%. Considering the fact that around 25,000 tonnes of additional capacity has to be created for L-Lysine Mono-hydrochloride to meet the global demand every year, it should be possible for the Indian project to take substantial share in the export market. This would be so, in view of the fact that the Molasses based L-Lysine project in India would be globally competitive from the point of view of the cost factors. The important aspects of the L-Lysine is that the product is based on cane molasses, which is adequately available in the country.
Plant capacity: 17 MT/DayPlant & machinery: Rs 328 Lakhs
Working capital: -T.C.I: Cost of Project: Rs 910 Lakhs
Return: 24.64%Break even: 52.18%
Add to Inquiry Add to Inquiry Basket

Information
  • One Lac / Lakh / Lakhs is equivalent to one hundred thousand (100,000)
  • One Crore is equivalent to ten million (10,000,000)
  • T.C.I is Total Capital Investment
  • We can modify the project capacity and project cost as per your requirement.
  • We can also prepare project report on any subject as per your requirement.
  • Caution: The project's cost, capacity and return are subject to change without any notice. Future projects may have different values of project cost, capacity or return.

Add multiple items to inquiry
Select the items and then press Add to inquiry button

Page 9 of 13 | Total 128 projects in this category
« Previous   Page 1 2 3 4 5 6 7 8 9 10 11 12 13   Next »

About NIIR PROJECT CONSULTANCY SERVICES

Hide »

NIIR PROJECT CONSULTANCY SERVICES (NPCS) is a reliable name in the industrial world for offering integrated technical consultancy services. NPCS is manned by engineers, planners, specialists, financial experts, economic analysts and design specialists with extensive experience in the related industries.

Our various services are: Detailed Project Report, Business Plan for Manufacturing Plant, Start-up Ideas, Business Ideas for Entrepreneurs, Start up Business Opportunities, entrepreneurship projects, Successful Business Plan, Industry Trends, Market Research, Manufacturing Process, Machinery, Raw Materials, project report, Cost and Revenue, Pre-feasibility study for Profitable Manufacturing Business, Project Identification, Project Feasibility and Market Study, Identification of Profitable Industrial Project Opportunities, Business Opportunities, Investment Opportunities for Most Profitable Business in India, Manufacturing Business Ideas, Preparation of Project Profile, Pre-Investment and Pre-Feasibility Study, Market Research Study, Preparation of Techno-Economic Feasibility Report, Identification and Selection of Plant, Process, Equipment, General Guidance, Startup Help, Technical and Commercial Counseling for setting up new industrial project and Most Profitable Small Scale Business.

NPCS also publishes varies process technology, technical, reference, self employment and startup books, directory, business and industry database, bankable detailed project report, market research report on various industries, small scale industry and profit making business. Besides being used by manufacturers, industrialists and entrepreneurs, our publications are also used by professionals including project engineers, information services bureau, consultants and project consultancy firms as one of the input in their research.

^ Top